Admedus Limited (ASX:AHZ) is pleased to announce it has renewed its exclusive distribution agreement with Utah-based Summit Medical Products Inc. (Summit) for a further eight years.

The updated arrangement confirms the longstanding relationship between the two Companies, which began in 2007, and secures a key component of Admedus’ infusion supply chain.

Under the terms of the extended agreement, Admedus remains the exclusive distributor of Summit’s ambIT® infusion products in Australia and New Zealand until 2026.

Admedus Head of Infusion, Mr Glenn Gilchrist welcomed the renewed agreement,

“Admedus has enjoyed a long and successful partnership with Summit Medical and we are delighted to renew this commitment for another eight years. Our team is proud to represent Summit’s range of innovative ambIT® products that deliver better outcomes for patients and add significant value to our infusion portfolio,” he said.

Summit Medical’s CEO Mr LeVoy Haight, also welcomed today’s announcement,

“Summit is pleased to continue working with Admedus, who shares our commitment to high-quality health solutions that improve the lives of patients. We welcome this agreement and look forward to building on our strong foundation to deliver long-term benefits to all parties.”